BACKGROUND: Ustekinumab (UST)is a fully human monoclonal antibody against IL-12/23 approved in Brazil for the treatment of moderate-to-severe Crohn’s disease (CD) in November 2017. UST ha...
BACKGROUND: Ustekinumab (UST)is a fully human monoclonal antibody against IL-12/23 approved in Brazil for the treatment of moderate-to-severe Crohn’s disease (CD) in November 2017. U...
BACKGROUND: Despite the numerous advances in medical treatment, it is estimated that a significant percentage of patients with Crohn's disease (CD) requires bowel resection at least once....
1 University of São Paulo School of Medicine, Department of Medicine, Ribeirão Preto, Brazil;
2 Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, ...
1 Faculdade de Medicina de Botucatu, Unesp, Assis, Brazil;
2 Faculdade de Medicina de Ribeirão Preto, Ribeirao Preto, Brazil;
3 University of State of Bahia, Salvador, Brazil;
4 Universid...
1 Bahia State University UNEB, Salvador, Brazil;
2 Faculdade de Medicina de Botucatu, Botucatu, Brazil;
3 Kaiser Hospital Dia, Department of Coloproctology, São José do Rio Preto, Brazil;...
BACKGROUND:
The IBD National Patient Registry is an initiative of the GEDIIB (Brazilian Study Group of Inflammatory Bowel Disease) who aims to survey the epidemiological profi...
1 Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Brazil, Ribeirao Preto, Brazil;
2 Ribeirao Preto Medical School, University of São Paulo, Braz...